Funding Information: In the preparation of this article, the authors received collaboration from the medical writer Duarte Oliveira (W4Research) financially supported by Sanofi. Sanofi had no role in the preparation of the manuscript or in the decision to submit the manuscript for publication. All authors declare collaborating and receiving fees from Sanofi and other pharmaceutical companies either through participation in advisory boards or consultancy, congress symposia, conducting clinical trials, investigator-initiated trials or grants. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.proofpublishe
Funding: ISAR is conducted by Optimum Patient Care Global Ltd, and co-funded by OPC Global Ltd and A...
The International Primary Care Respiratory Group (IPCRG) has facilitated the publication of this pap...
Funding This study was sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. Acknowledgments At th...
Funding Information: João Gaspar Marques has received research grants from AstraZeneca and honorariu...
Funding Information: Conflict of interest: G. Paoletti reports no conflict of interest. J. Pepys rep...
[Excerpt] Introduction: Asthma has a high prevalence worldwide with a high incidence in primary care...
Journal Article; Research Support, Non-U.S. Gov't;BACKGROUND Some patients with COPD may share char...
Although the prevalence of severe asthma is not high (5–10% of patients), it is responsible for a la...
Allergic asthma is characterised by the presence of circulating specific immunoglobulin E (IgE) or a...
Funding AstraZeneca funded the SABINA III study; was involved in the study design, protocol developm...
Fractional exhaled nitric oxide (FeNO) is the only available point of care test to assess type-2 inf...
FEF25-75 should be incorporated to assess improvement in small airways dysfunction (SAD) for severe ...
Acknowledgments The authors would like to acknowledge Dr. James Zangrilli and Dr. Alex de Giorgio-Mi...
The European Academy of Allergy and Clinical Immunology (EAACI) organised the first European Strateg...
Funding: This study was conducted by the Observational and Pragmatic Research Institute (OPRI) Pte L...
Funding: ISAR is conducted by Optimum Patient Care Global Ltd, and co-funded by OPC Global Ltd and A...
The International Primary Care Respiratory Group (IPCRG) has facilitated the publication of this pap...
Funding This study was sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. Acknowledgments At th...
Funding Information: João Gaspar Marques has received research grants from AstraZeneca and honorariu...
Funding Information: Conflict of interest: G. Paoletti reports no conflict of interest. J. Pepys rep...
[Excerpt] Introduction: Asthma has a high prevalence worldwide with a high incidence in primary care...
Journal Article; Research Support, Non-U.S. Gov't;BACKGROUND Some patients with COPD may share char...
Although the prevalence of severe asthma is not high (5–10% of patients), it is responsible for a la...
Allergic asthma is characterised by the presence of circulating specific immunoglobulin E (IgE) or a...
Funding AstraZeneca funded the SABINA III study; was involved in the study design, protocol developm...
Fractional exhaled nitric oxide (FeNO) is the only available point of care test to assess type-2 inf...
FEF25-75 should be incorporated to assess improvement in small airways dysfunction (SAD) for severe ...
Acknowledgments The authors would like to acknowledge Dr. James Zangrilli and Dr. Alex de Giorgio-Mi...
The European Academy of Allergy and Clinical Immunology (EAACI) organised the first European Strateg...
Funding: This study was conducted by the Observational and Pragmatic Research Institute (OPRI) Pte L...
Funding: ISAR is conducted by Optimum Patient Care Global Ltd, and co-funded by OPC Global Ltd and A...
The International Primary Care Respiratory Group (IPCRG) has facilitated the publication of this pap...
Funding This study was sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. Acknowledgments At th...